Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSGeneric

ARGATROBAN IN 0.9% SODIUM CHLORIDE

ARGATROBAN

Standard Dose
250MG/250ML (1MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview ARGATROBAN IN 0.9% SODIUM CHLORIDE is listed in Drugs@FDA under application 206769 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient ARGATROBAN Form and strength INJECTABLE;INTRAVENOUS - 250MG/250ML (1MG/ML) Sponsor TEVA PHARMS USA Submission history Latest submission status date: 2019-07-29 00:00:00.

Structured Monograph

Clinical summary

Approval overview ARGATROBAN IN 0.9% SODIUM CHLORIDE is listed in Drugs@FDA under application 206769 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient ARGATROBAN Form and strength INJECTABLE;INTRAVENOUS - 250MG/250ML (1MG/ML) Sponsor TEVA PHARMS USA Submission history Latest submission status date: 2019-07-29 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.